Description
Each vial contains 20mg of highly pure Retatrutide.
Retatrutide is an investigational peptide that acts as a triple hormone receptor agonist, targeting the GLP-1, GIP, and glucagon (GCGR) receptors. By activating all three pathways, it is designed to support significant weight loss, reduce body fat, and improve metabolic health, with research suggesting it may produce greater effects than earlier GLP-1–based therapies.
Reconstitution
Add 2mL of bacteriostatic water to get a solution that is 10mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 1mg of Retatrutide.
Storage
This product must be refrigerated after reconstitution.
